Clinical & Pharma

Mass Photometry Transforms Gene Therapy Characterization
Clinical & Pharma Mass Photometry Transforms Gene Therapy Characterization

The biological complexity of viral vectors has historically pushed the limits of traditional analytical chemistry, often leaving researchers to navigate a landscape of uncertainty where even minor process deviations can jeopardize the safety and efficacy of a potential cure. As the gene and cell

How Do Subclinical Carriers Drive the Global TB Epidemic?
Clinical & Pharma How Do Subclinical Carriers Drive the Global TB Epidemic?

Public health strategies have traditionally prioritized the identification of individuals exhibiting the overt physical manifestations of tuberculosis, such as chronic coughing, fever, and weight loss. This symptom-based approach, while effective at treating those in immediate distress, has failed

How Will New Reforms Modernize U.S. Clinical Trials?
Clinical & Pharma How Will New Reforms Modernize U.S. Clinical Trials?

The current state of the United States clinical research sector highlights a growing tension between rapid scientific innovation and the sluggish mechanisms used to validate new therapies for public use. While laboratory discoveries have accelerated at an unprecedented pace, the administrative and

UNT Health Launches DFW’s First Pharmaceutical PhD Program
Clinical & Pharma UNT Health Launches DFW’s First Pharmaceutical PhD Program

The University of North Texas Health Science Center at Fort Worth has officially established the first Doctor of Philosophy program in Pharmaceutical Sciences in the Dallas-Fort Worth metroplex, marking a significant milestone for regional medical research. This strategic expansion addresses a

Are Urine Dipsticks Reliable for Geriatric UTI Diagnosis?
Clinical & Pharma Are Urine Dipsticks Reliable for Geriatric UTI Diagnosis?

Diagnosing a urinary tract infection in an older adult often involves navigating a complex web of atypical symptoms that bear little resemblance to the localized pain or burning experienced by younger populations. Instead of the classic presentation, clinicians frequently encounter non-specific

New Research Highlights Cannabinoid Anti-Tumor Potential
Clinical & Pharma New Research Highlights Cannabinoid Anti-Tumor Potential

The long-standing skepticism surrounding the clinical utility of cannabis-derived compounds is rapidly giving way to a new era of rigorous, data-driven oncological investigation. A comprehensive systematic review recently conducted by researchers from Semmelweis University and the University of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later